Corporate presentation
Logotype for Mitsui Chemicals Inc

Mitsui Chemicals (4183) Corporate presentation summary

Event summary combining transcript, slides, and related documents.

Logotype for Mitsui Chemicals Inc

Corporate presentation summary

11 Nov, 2026

Portfolio transformation

  • Acquisition of JSR is positioned as a portfolio shift toward global specialty materials, not only an expansion of semiconductor materials; further M&A and alliances are part of the strategy.

  • FY30 target: core operating profit of at least ¥300bn, exceeding the prior ¥250bn goal; EPS growth is intended to lift enterprise value.

  • The two-axis portfolio centers on L&HC and ICT for growth, and B&GM and Mobility for polymer-chain scale; B&GM separation is planned for FY27.

  • Growth-area core operating profit growth slowed from 13% in FY19–FY23 to 5% in FY23–FY25; B&GM recorded core operating losses for three consecutive years.

JSR acquisition and ICT positioning

  • JSR FY25 revenue was ¥440.7bn and operating profit ¥62.3bn; its Digital Solutions business generated ¥252.1bn revenue, ¥63.2bn core operating profit and 25.1% ROS.

  • JSR brings semiconductor and optical materials, including photoresists, CMP slurries and ALD/CVD materials; its photoresist portfolio ranked No. 2 globally, with CAR and MOR solutions for EUV.

  • The semiconductor market is forecast to grow at a CAGR of 10% or more from 2025, supporting demand for a broader materials portfolio.

  • Purchase price is ¥1,392.1bn for 100% of shares; assumed closing debt and other liabilities are ¥447.9bn, and EV/EBITDA is 16x on the FY26 outlook basis.

  • Closing is expected in H2 FY27, subject to regulatory approvals; DBJ will invest ¥200bn in non-voting preferred shares.

Value creation and synergy targets

  • Combining customer bases, products and technologies is intended to accelerate development, cross-selling and new product creation across semiconductor and optical materials.

  • Target incremental synergy by FY35 is ¥40bn: ¥20bn from sales growth and ¥20bn from cost optimization; cost actions include optimizing headquarters, R&D and overseas sites.

  • FY30 ICT core operating profit target is at least ¥190bn; the FY35 estimate is at least ¥190bn after integration and PPA amortization, with synergy effects included.

  • The combined portfolio is intended to establish a presence among core semiconductor-market players and make ICT the leading profit pillar of the transformed portfolio.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Mitsui Chemicals